Gebro Pharma AG
Gebro Pharma AG is a Generics company based in Liestal (Basel-Landschaft) recorded by Swissmedic as the authorisation holder for 32 human medicines. That places it 51 of 334 authorisation holders in Switzerland. Its portfolio is concentrated in Synthetika.
Key facts
| Sector | Generics |
|---|---|
| City | Liestal |
| Canton | Basel-Landschaft |
| Authorisation holder | Yes |
| Medicines | 32 |
| Founded | 1977 |
| Employees | 51-200 |
| Parent group | Gebro Holding GmbH |
| Activity | Not available |
| Website | gebro.ch |
Medicines authorised in Switzerland
Gebro Pharma AG is recorded by Swissmedic as the authorisation holder for 32 human medicines. The table shows 32 of them with product code and dispensing category.
Portfolio by product code
Portfolio by dispensing category
32 of 32 authorisations
| Name | Authorisation number | Dispensing category | ATC | First authorised |
|---|---|---|---|---|
| Alacare 2 mg/cm2 | 62687 | B | L01XD04 | 2013-02-18 |
| Axhidrox 2 | 69243 | B | D11AA01 | 2024-06-27 |
| Becetamol C | 55651 | D | - | 2001-05-04 |
| Dalingo 82.5 mg | 69956 | B | N02BF02 | 2025-10-07 |
| Dexibuprofen Fairmed 200 mg | 68144 | B | - | 2022-07-15 |
| GeloDurat | 55928 | D | R05CA | 2003-11-24 |
| Hova | 51838 | D | N05CX | 1992-12-18 |
| Lactoferment 10 | 51102 | D | A07FA01 | 1994-02-25 |
| Lactoferment 5 | 53746 | D | A07FA01 | 1996-08-07 |
| Lactéol 5 | 42185 | D | - | 1980-03-07 |
| Laxasan | 49798 | D | A06AB08 | 1989-04-24 |
| Leflunomid Gebro 10 mg | 61443 | A | L04AK01 | 2011-07-15 |
| Levocalm 30 mg / 5 ml | 69413 | D | R05DB27 | 2024-07-18 |
| Makatussin | 55274 | B | R05DA04 | 2000-10-03 |
| Makatussin Comp. | 39255 | B | R05DA20 | 1976-06-29 |
| Metofol 5mg | 65228 | B | B03BB01 | 2014-03-05 |
| Metoject 7.5 mg | 57272 | A | L04AX03 | 2005-09-02 |
| Metoject Autoinjektor 7.5 mg/0.15 ml | 65672 | A | L04AX03 | 2017-03-17 |
| Nitrolingual | 40558 | B | C01DA02 | 1977-11-28 |
| Nocutil | 54616 | B | H01BA02 | 1998-06-17 |
| Nocutil 0 | 57377 | B | H01BA02 | 2006-06-29 |
| Normolytoral | 43916 | D | A07CA | 1981-10-05 |
| Ovixan 1 mg/g | 65525 | B | D07AC13 | 2015-10-27 |
| Pennsaid 2 g / 100 g | 67138 | D | M02AA15 | 2020-01-13 |
| Remodulin 1 mg/ml | 56120 | B | B01AC21 | 2004-11-26 |
| Sanalgin N | 55339 | D | N02BE51 | 2000-05-11 |
| Seractil 200 mg | 54767 | B | M01AE14 | 2000-06-28 |
| Seractil 200 mg | 57985 | B | M01AE14 | 2010-08-24 |
| Tavegyl | 35501 | B | R06AA04 | 1970-06-03 |
| Triamject 20 mg | 62962 | B | - | 2014-09-04 |
| Unguentolan | 13188 | D | D03AA | 1948-12-09 |
| Vivena 1000 mg | 69834 | D | C05CA03 | 2025-03-17 |
Frequently asked questions
How many medicines does Gebro Pharma AG have authorised in Switzerland?
Gebro Pharma AG is recorded by Swissmedic as the authorisation holder for 32 human medicines (as of 1 September 2026). Different strengths under one authorisation number are not counted separately.
Where is Gebro Pharma AG based?
The Swiss location recorded for Gebro Pharma AG is Liestal, Basel-Landschaft.
Is Gebro Pharma AG a Swissmedic authorisation holder?
Yes. Gebro Pharma AG appears in the official Swissmedic list of authorised medicinal products as an authorisation holder. Under the Therapeutic Products Act (TPA) the holder is responsible for the quality, safety and product information of its medicines in Switzerland.